歡迎選擇我們,上海恒遠(yuǎn)生物科技有限公司!免費服務(wù)熱線:400-0899-208 防偽查詢
語言:Eng
公司簡介 企業(yè)文化 合作伙伴 公司福利
公司新聞 行業(yè)新聞
免疫學(xué)檢測 生化檢測 病理學(xué)檢測 分子生物學(xué)檢測 細(xì)胞實驗
技術(shù)支持 常見問題解答 說明書下載 產(chǎn)品文獻(xiàn)
聯(lián)系方式 在線留言
恒遠(yuǎn)生物抗體平臺現(xiàn)已擁有4萬多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關(guān)抗體、小分子抗體、二抗、標(biāo)簽抗體及內(nèi)參抗體等。并以每年4000種的速度在持續(xù)增長。
恒遠(yuǎn)生物擁有專業(yè)的質(zhì)控團(tuán)隊,配備先進(jìn)實驗儀器,現(xiàn)已成功地建立了ChIP平臺,因此我們的抗體不僅能提供Biotin、FITC、HRP等標(biāo)記,大部分抗體都能進(jìn)行ELISA、WB、IHC、IF、IP、ChIP等應(yīng)用驗證。
我們致力于為所有用戶提供高親和力、高特異性的優(yōu)質(zhì)抗體,歡迎來電咨詢。
This SARS-CoV-2 S1-RBD (Spike Glycoprotein S1 receptor-binding domain) antibody is a recombinant monoclonal antibody (also a Nanobody) generated through the expression of a DNA sequence inserting a human IgG1 Fc domain at the C-terminus, in human embryonic kidney 293 cells (HEK293). The DNA sequence encodes the SARS-CoV-2 spike RBD. The antibody is purified by protein G in vitro. It has been validated with high reactivity towards SARS-CoV-2 S1-RBD by a functional ELISA and good sensitivity for human SARS-CoV-2 spike glycoprotein (S protein) via the Colloidal Gold Immunochromatography Assay (GICA). It is also validated in Neutralizing and LSPR. In neu assay, the binding signal of the SARS-CoV-2 S1 RBD antibody was inhibited by ACE2 protein-HRP conjugated inhibitor, with a 0.1074 μg/ml IC50. In LSPR assay, the SARS-CoV-2 S1 RBD antibody showed a high affinity with SARS-CoV-2 Spike protein RBD (affinity constant: 28.2nM). Specifically binding and recognizing the RBD of the SARS-CoV-2 spike glycoprotein, the SARS-CoV-2 S1 RBD antibody can react with samples infected with human coronavirus SARS-CoV-2. But it does not respond to MERS or SARS-CoV spike protein. Akin to other nanobodies, this recombinant nanobody is small and stable, which allows for its reaching to hidden epitopes such as crevices of target proteins.
N Antibody
SARS-CoV-2 Spike RBD Nanobody, HRP conjugated
SARS-CoV-2 Spike RBD Nanobody, FITC conjugated
SARS-CoV-2 Spike RBD Nanobody, Biotin conjugated
Phospho-Histone H3.3 (T3) Antibody
Di-methyl-Histone H3.1(K4)Antibody
恒遠(yuǎn)生物抗體平臺現(xiàn)已擁有4萬多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關(guān)抗體、小分子抗體、二抗、標(biāo)簽抗體及內(nèi)參抗體等。并以每年4000種的速度在持續(xù)增長。
請輸入搜索關(guān)鍵字